Volume 11, Issue 5, September 2017

Index

PRACTICE GUIDELINES

Therapy-orienting testing of EGFR inhibitor-resistant non-small cell lung cancer

C. Dooms, B. Colinet, I. Demedts, N. D’Haene, V. Ninane, T. Pieters, J. Vansteenkiste, B. Weynand, P. Pauwels


PHARMACOTHERAPY

CDK 4/6 inhibitors in the treatment of advanced breast cancer

L. Lallemand, F.P. Duhoux


RESEARCH

Lung cancer screening programs: black or white?

E. Bustamante, C. Soza-Ried, C. Rolfo, L.E. Raez, V. Domínguez, E.S. Santos, C. Caglevic


REIMBURSEMENT NEWS

New oncology reimbursements in Belgium

P. Specenier


X